Status:
COMPLETED
Effect of a Modified 5:2 Intermittent Fasting Diet on Population With Overweight or Obesity in China
Lead Sponsor:
Zhejiang Provincial Tongde Hospital
Conditions:
Overweight or Obesity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aimed to investigate the effects of the modified 5:2 IF dietary intervention on the Chinese population with overweight or obesity based on a self-controlled clinical trial.
Detailed Description
There are fewer studies on the influence of dietary interventions on the Chinese populations with obesity, and the degree of obesity, body fat distribution, dietary pattern and structure, and metaboli...
Eligibility Criteria
Inclusion
- participants aged 18 to 60 years
- participants with a body mass index (BMI) ≥ 24 kg/m2
- participants engaged in light physical labor and their weight was relatively stable.
Exclusion
- participants taking any medication with an effect on body weight in the three months prior to enrollment;
- participants with liver or kidney dysfunction (liver enzymes ≥ 2 times normal; blood creatinine \> the upper limit of normal);
- participants with a history of cardiovascular disease (e.g., coronary heart disease, stroke);
- participants with malignant tumors;
- women during pregnancy or breastfeeding;
- participants deemed unsuitable by the investigator to participate in this trial.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06552403
Start Date
January 1 2022
End Date
December 31 2023
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiaoli Wang
Hangzhou, China